Big Chemical Encyclopedia

Chemical substances, components, reactions, process design ...

Articles Figures Tables About

Cardiology acute coronary syndromes

The American Heart Association and the American College of Cardiology recommend strategies, or guidelines, for acute coronary syndrome patient care for ST-segment and non-ST-segment elevation acute coronary syndrome. [Pg.83]

Palmer, S., M. Sculpher, M. Robinson Philips, L. Ginnelly, and D. Gary. 2005. Management of Non-ST-Elevation Acute Coronary Syndromes How Cost-Effective Are Glycoprotein Ilb/IIIa Antagonists in the UK National Health Service International Journal of Cardiology 100(2) 229-240. [Pg.310]

Bertrand ME, Simoons ML, Fox KA, et al, Task force on the management of acute coronary syndromes of the European Society of Cardiology, Management of acute coronary syndromes in patients presenting without persistent ST-segment elevation, Eur Heart J 2002 23 1 809-1 840. [Pg.124]

Lemos PA, Lee CH, Degertekin M, etal. Early outcome after sirolimus-eluting stent implantation in patients with acute coronary syndromes insights from the Rapamycin-Eluting Stent Evaluated At Rotterdam Cardiology Hospital (RESEARCH) registry, J Am Coll Cardiol 2003 41(1 l) 2093-2099. [Pg.261]

The introduction of stents in interventional cardiology has added a new dimension in the management of acute coronary syndrome and related disorders. Moreover, stents are now commonly used in the management of vascular and... [Pg.613]

Jaffe AS, Davidenko J, Clements I. Diagnosis of acute coronary syndromes including myocardial infarction. In Crawford MH, DiMarco JP, Paulus WJ, eds. Cardiology. 2nd ed. St Louis Mosby 2004 311-28. [Pg.1665]

ACC American College of Cardiology ACE angiotensin-converting enzyme ACS acute coronary syndrome ACT activated clotting time ADP adenosine diphosphate AHA American Heart Association aPTT activated partial thromboplastin time ARB angiotensin-receptor blocker... [Pg.315]

Table 2.1 American College of Cardiology/American Heart Association system for risk stratification of patients with non-ST-elevation acute coronary syndromes... [Pg.23]

Fraley AE, Schwartz GG, Olsson AG et al. Relationship of oxidized phospholipids and biomarkers of oxidized low-density hpoprotein with cardiovascular risk factors, inflammatory biomarkers, and effect of statin therapy in patients with acute coronary syndromes Results from the MIRACL (Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering) trial. Journal of the American CollMe of Cardiology 2009 53 2186-2196. [Pg.305]

Serum biomarkers of acute coronary syndrome play a critical role in the diagnosis and risk stratification of patients with ACS. Myocardial necrosis observed in patients with ACS releases a variety of proteins into blood that can be used as biomarkers. Antiquated markers include aspartate aminotransferase, lactate dehydrogenase (LD) and its isoenzyme (LDl), myoglobin, and creatine kinase (CK) and its isoenzyme (CK-MB). While some of these markers are still in routine use, there is consensus among experts in the field of cardiology, emergency medicine, and laboratory medicine that cardiac troponin is the gold standard marker for ACS. [Pg.1807]

See other pages where Cardiology acute coronary syndromes is mentioned: [Pg.83]    [Pg.84]    [Pg.84]    [Pg.84]    [Pg.84]    [Pg.95]    [Pg.58]    [Pg.62]    [Pg.68]    [Pg.669]    [Pg.669]    [Pg.45]    [Pg.49]    [Pg.55]    [Pg.1656]    [Pg.123]    [Pg.193]   
See also in sourсe #XX -- [ Pg.124 ]



SEARCH



Cardiology

Coronary syndromes

© 2024 chempedia.info